Welcome to LookChem.com Sign In|Join Free
  • or
3-E-benzylidene-6-[5-(1,1-dimethylallyl)-1H-imidazol-4-Z-ylmethylene]-piperazine-2,5-dione is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

507485-39-4

Post Buying Request

507485-39-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

507485-39-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 507485-39-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,7,4,8 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 507485-39:
(8*5)+(7*0)+(6*7)+(5*4)+(4*8)+(3*5)+(2*3)+(1*9)=164
164 % 10 = 4
So 507485-39-4 is a valid CAS Registry Number.

507485-39-4Relevant academic research and scientific papers

A novel potent cell cycle inhibitor dehydrophenylahistin. - Enzymatic synthesis and inhibitory activity toward sea urchin embryo

Kanzaki, Hiroshi,Yanagisawa, Satohiro,Kanoh, Kaneo,Nitoda, Teruhiko

, p. 1042 - 1047 (2002)

A novel dehydrogenated cyclic dipeptide named as dehydrophenylahistin (APLH) was effectively prepared from a fungal metabolite (-)-phenylahistin by the enzymatic conversion catalyzed by the cell-free extract of Streptomyces albulus KO-23, an albonoursin-producing actinomycete. ΔPLH exhibited more than 1,000 times as high potent inhibitory activity toward the first cleavage of sea urchin embryos as (-)-phenylahisitn which has been reported to be a cell cycle inhibitor and more than 10,000 as high as albonoursin, indicating that ΔPLH is a promising leading compound for anticancer drugs.

ANALOGS OF DEHYDROPHENYLAHISTINS AND THEIR THEAPEUTIC USE

-

Page/Page column 25-26, (2008/12/08)

Compounds represented by the following structure (II) are disclosed: as are methods for making such compounds. Compositions and methods for treating various disease conditions including cancer and non-cancer diseases associated with vascular proliferation are also disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 507485-39-4